ArticleFrontiers in cellular and infection microbiology2025
Clinical characterisation of human metapneumovirus infection in 525 patients with respiratory tract infections in Jilin province.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Gut microbiota and serum metabolome in children with human metapneumovirus infection.Frontiers in immunology · 2026Article
- Genetic and epidemiological characteristics of the spread of human metapneumovirus in Bulgaria, 2023-2025.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Human metapneumovirus (HMPV) is a common cause of acute respiratory infections. The aim of this study was to analyze the demographic characteristics and treatment outcomes of HMPV virus infection in Jilin province. Methods: We conducted a retrospective cohort analysis of patients with respiratory tract infections between September 2023 and February 2024 in the Lequn Campus of the First Hospital of Jilin University, using tNGS sequencing. This study focused on HMPV-infected patients and included infections with this virus alone as well as co-infections. Results: In the present study, 525 patients with respiratory diseases were analysed, 65 (12.57%) of whom were found to be infected with HMPV. The period of maximum human metapneumovirus infection was observed to be January, and of the 65 patients infected with this virus, 10 (15.2%) were infected with HMPV alone and 56 (84.8%) were co-infected with HMPV. The most prevalent co-infection was bacterial, with the most common identified pathogen being human herpesvirus, followed by Candida albicans and Streptococcus pneumoniae. The percentage of co-infections in patients not infected with HMPV was 78.87%. Patients infected with HMPV alone exhibited a lower proportion of males, elevated rates of fever and cough, and a higher prevalence of diabetes mellitus and CURB-65 score (P>0.05). The most prevalent initial diagnoses were pneumonia, with additional respiratory failure and hypoproteinaemia diagnoses. Furthermore, a higher proportion of patients infected with the HMPV virus were hospitalised for more than 10 days compared with those not infected with the virus. Conclusion: HMPV is easily neglected in the current diagnosis and treatment process, but the risk it poses, such as long hospitalisation, should not be ignored. The tNGS showed excellent detection performance and great potential in this study, and it can be a good tool to help clinicians in diagnosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.